>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Wednesday 10 July 2024
08:30 - 09:30
Session 72: Fertilty preservation in endometriosis: current trends and future directions
Wednesday 10 July 2024
08:30 - 09:30: Session 72: Fertilty preservation in endometriosis: current trends and future directions:
08:30 - 08:50
Indication for fertility preservation in patients with endometriosis
09:00 - 09:20
Techniques and outcomes of fertility preservation in patients with endometriosis
08:30 - 09:30
Session 73: Pregnancy loss trios
08:30 - 09:30: Session 73: Pregnancy loss trios:
08:30 - 08:50
Why one is not enough when studying pregnancy loss - a European perspective
Tanja Schlaikjær Hartwig, Denmark
09:00 - 09:20
Why one is not enough when studying pregnancy loss - an American perspective
08:30 - 09:30
Session 74: ALMER Exchange session: Are we in the era of Precision Reproductive Medicine?
08:30 - 09:30: Session 74: ALMER Exchange session: Are we in the era of Precision Reproductive Medicine?:
Ester Polak de Fried, Argentina
Sergio Dario Papier, Argentina
08:30 - 09:00
Artificial intelligence in the assessment of oocyte quality and endometrial receptivity
09:00 - 09:30
Automation in the embryology laboratory
08:30 - 09:30
Session 75: Guidelines session:ESHRE Guidelines: Focus on embryos
08:30 - 09:30: Session 75: Guidelines session:ESHRE Guidelines: Focus on embryos:
08:30 - 08:50
Embryo assessment: The Istanbul consensus revised
Giovanni Coticchio, Italy
09:00 - 09:20
ESHRE guidance on embryo transfer: when to do DET?
08:30 - 09:30
Session 76: IFFS session: Fertility Free Fall - where do you stand?
08:30 - 09:30: Session 76: IFFS session: Fertility Free Fall - where do you stand?:
Chair invited, but not yet confirmed
08:30 - 08:50
Why do we need to act NOW?
Bart C.J.M. Fauser, The Netherlands
08:50 - 09:10
Promoting family building strategies - a global call to action
08:30 - 09:30
Session 77: ASPIRE Exchange session: The Relevance of AMH in 2024
08:30 - 09:30: Session 77: ASPIRE Exchange session: The Relevance of AMH in 2024:
Chair invited, but not yet confirmed
08:30 - 08:50
AMH levels in infertile women in APAC region - prospective study in multiple countries, ethnicities and centres
Chii-Ruey Tzeng, Taiwan R.O.C.
09:00 - 09:20
Is Measuring AMH Relevant for Egg Freezing in Young Oncology Patients?
08:30 - 09:30
Session 78: Poster discussion session
08:30 - 09:30: Session 78: Poster discussion session:
09:30 - 10:00
Coffee break in the exhibit hall
09:30 - 10:00: Coffee break in the exhibit hall:
10:00 - 11:30
Session 79: Embryo Selection Refinement with AI
10:00 - 11:30: Session 79: Embryo Selection Refinement with AI:
Ioannis Sfontouris, Greece
Josien G. Derhaag, The Netherlands
10:00 - 10:15
A cutting-edge Artificial Intelligence system tracking embryo development and pinpointing the optimal day for blastocyst utilization
Raquel Del Gallego, United Arab Emirates
10:15 - 10:30
Validation of an AI (Artificial intelligence) model assessing oocyte quality in a single donor program with frozen-thawed oocytes for blastocyst prediction
Eleni Linara, United Kingdom
10:30 - 10:45
Novel early cleavage parameters improve embryo selection and reach ploidy predictive values comparable to artificial intelligence
Clara Serrano Novillo, Spain
10:45 - 11:00
METAPHOR: METabolic imaging through AI-powered Phasor-based Hyperspectral analysis and Organelle recognition for the classification of human blastocysts
11:00 - 11:15
Never a lost cause: can artificial intelligence (AI)-powered ranking help decrease time to pregnancy when only poor-quality embryos are available?
Alexandra Boussommier, France
11:15 - 11:30
Generative Artificial Intelligence Substantially Enhances the Accuracy of Embryo Selection Models
Ping Cao, The Netherlands
10:00 - 11:30
Session 80: Risk factors and predictive models in ART
10:00 - 11:30: Session 80: Risk factors and predictive models in ART:
Ying Cheong, United Kingdom
Jesper M.J. Smeenk, The Netherlands
10:00 - 10:15
Cumulative live birth rates (CLBR) in in vitro fertilization per oocyte used, embryo transferred, and embryo transfer impair with increasing female body mass index (BMI)
JOSE BELLVER PRADAS, Spain
10:15 - 10:30
Altered Telomerase Activity in Ovarian Follicular Cells in Patients with Polycystic Ovary Syndrome
Harpreet kaur Lamsira, Italy
10:30 - 10:45
The relationship between dysbiosis of vaginal microbiome and proinflammatory cytokine levels in vaginal fluid in recurrent implantation failure patients.
10:45 - 11:00
Ovarian Response Prediction Index (ORPI) as a predictor tool for ovarian response and clinical pregnancy in IVF/ICSI cycle : A Prospective Cohort Study
11:00 - 11:15
Evaluation of Anti-Mullerian hormone levels in reproductive age severely obese women six months after bariatric surgery
11:15 - 11:30
Comparing the accuracy of the novel clustering model versus phenotype classification in predicting live birth in polycystic ovary syndrome women undergoing In-Vitro fertilization.
Tran Thai Huu Loc, Vietnam
10:00 - 11:30
Session 81: Testicular sperm extraction: From sperm retrieval to patient follow-up
10:00 - 11:30: Session 81: Testicular sperm extraction: From sperm retrieval to patient follow-up:
Chair invited, but not yet confirmed
Marij Smit, The Netherlands
10:00 - 10:15
Clinical factors associated with sperm retrieval success in hypogonadal nonobstructive azoospermic males undergoing microdissection testicular sperm extraction
10:15 - 10:30
Seminal plasma cell-free RNA to predict testicular biopsy sperm retrieval outcome in azoospermic men
10:30 - 10:45
Identifying seminiferous tubules for sperm retrieval during microdissection testicular sperm extraction (M-TESE) using deep learning
10:45 - 11:00
Frozen gametes differ in post-insemination dynamics to their fresh sibling counterparts in cycles using testicular sperm
Virginia Ferracuti, United Arab Emirates
11:00 - 11:15
Karyotyping of single sperm from non-obstructive azoospermia patients and obstructive azoospermia patients using a combination of micromanipulation and next-generation sequencing.
11:15 - 11:30
The risk of hypogonadism after microdissection testicular sperm extraction (micro TESE) in non-obstructive azoospermia (NOA) patients with various etiologies.
10:00 - 11:30
Session 82: Uterine disorders management in the -omics era
10:00 - 11:30: Session 82: Uterine disorders management in the -omics era:
Erin Greaves, United Kingdom
10:00 - 10:15
Profiling Tumor-Initiating Cells in Uterine Leiomyoma through Single-Cell Multi-omics
Aymara Mas Perucho, Spain
10:15 - 10:30
Mapping Decidualization Resistance at Multi-Omic Level
10:30 - 10:45
Multi-omics landscape of uterine fluid-derived extracellular vesicles across the menstrual cycle
Apostol Apostolov, Estonia
10:45 - 11:00
Extracellular vesicles as biomarkers of endometriosis
Thomas Tapmeier, Australia
11:00 - 11:15
Re-considering the Endometrial Microbiome: A Comparison of DNA- and RNA-Based Sequencing Techniques Within the Same Cohort.
Alberto Sola-Leyva, Sweden
11:15 - 11:30
Long term efficacy of Linzagolix in women with endometriosis-associated pain.
Marie-Madeleine Dolmans, Belgium
10:00 - 11:30
Session 83: Unveiling Current Innovations in Experimental PGT and PND
10:00 - 11:30: Session 83: Unveiling Current Innovations in Experimental PGT and PND:
Efthymia Constantinou, Cyprus
Chair invited, but not yet confirmed
10:00 - 10:15
Clinical-grade whole genome sequencing-based haplarithmisis enables all forms of preimplantation genetic testing
Anouk Janssen, The Netherlands
10:15 - 10:30
Two component resolution of mosaic samples in PGT-A: primary template amplification (PTA) and independent analysis using copy-number variation and allelic balance
Christopher Weier, U.S.A.
10:30 - 10:45
Preimplantation genetic testing of the first polar body is useful for predicting embryo euploidy: data from 1,836 donor oocytes
10:45 - 11:00
A transcriptomic approach for embryo selection after preimplantation genetic diagnosis for aneuploidy
11:00 - 11:15
An Artificial Intelligence (AI) based screening test can reliably predict embryo ploidy
11:15 - 11:30
Prenatal genetic screening to assess mtDNA disease occurrence in children.
Shoukhrat Mitalipov, U.S.A.
10:00 - 11:30
Session 84: Microbiome matters: Insights into Maternal infections, Treatments Outcomes and Reproductive Health
10:00 - 11:30: Session 84: Microbiome matters: Insights into Maternal infections, Treatments Outcomes and Reproductive Health:
Chair invited, but not yet confirmed
10:00 - 10:15
Implantation failure is not associated with seven different vaginal bacterial community-state types; however, a distinct signature, including Ureaplasma parvum, is strongly linked to treatment failure
Marion Depenbusch, Germany
10:15 - 10:30
Exploring the relationship between the vaginal microbiota and vaginal symptoms
10:30 - 10:45
The vaginal and endometrial microbiome: do they tell the same story?
Courtney Povey, United Kingdom
10:45 - 11:00
The lower reproductive tract microbiota composition alters upon ovarian stimulation and is associated with, but not accurately predictive of reproductive outcomes following ART
11:00 - 11:15
Vaginal microbiota transplant (VMT) without antibiotic pretreatment reveals changes in vaginal microbiota and immune profile in women with asymptomatic dysbiosis – a randomized, placebo-controlled trial
Johan E.T. van Hylckama Vlieg, Denmark
11:15 - 11:30
Characterization of Vaginal microbiota and reproductive outcomes associated with assisted reproductive technologies through next-generation sequencing, from Indian population
Dr. Manisha Vajpeyee, India
10:00 - 11:30
Session 85: Poster discussion session
10:00 - 11:30: Session 85: Poster discussion session:
11:45 - 12:45
Session 86: Safety issues for restoration of fertility using cryopreserved tissues and cells
11:45 - 12:45: Session 86: Safety issues for restoration of fertility using cryopreserved tissues and cells:
11:45 - 12:05
Detection and elimination of malignant cells from cryopreserved testis and ovarian tissue?
Kirsi Jahnukainen, Finland
12:15 - 12:35
Preventing transmission of genetic disorders in embryos and gametes
Helen O'Neill, United Kingdom
11:45 - 12:45
Session 87: The Yin to my Yang: gamete compatibility in reproductive partners
11:45 - 12:45: Session 87: The Yin to my Yang: gamete compatibility in reproductive partners:
11:45 - 12:05
Evidence for gamete recognition mechanisms in humans
12:15 - 12:35
Incompatible gametes: implications for infertility diagnosis and treatment
Jukka Kekäläinen, Finland
11:45 - 12:45
Session 88: Preconception weight intervention
11:45 - 12:45: Session 88: Preconception weight intervention:
11:45 - 12:05
Weight loss interventions prior to infertility treatment does it make sense?
Annemieke Hoek, The Netherlands
12:15 - 12:35
Body composition analysis and metabolic monitoring before fertility treatment: hype or hope?
Elisabeth De Waele, Belgium
11:45 - 12:45
Session 89: Debate: Commercialisation is a necessity for ART to flourish
11:45 - 12:45: Session 89: Debate: Commercialisation is a necessity for ART to flourish:
Lucy van de Wiel, United Kingdom
Lucy van de Wiel, United Kingdom
11:45 - 12:45
Session 90: Ultrasound in infertility
11:45 - 12:45: Session 90: Ultrasound in infertility:
Chair invited, but not yet confirmed
Karst Heida, The Netherlands
11:45 - 12:00
Reduced uterine artery pulsatility index (UtAPI) in artificial frozen embryo transfer pregnancies leads to underestimation of 1st-trimester preeclampsia risk. An analysis of over 30,000 pregnancies.
Nikolaos P. Polyzos, Spain
12:00 - 12:15
Sonographic Symphony: A systematic review and network meta-analysis of the use of 2D, 3D, 4D ultrasound's influence on embryo transfer outcomes
Ranjana Raj, United Kingdom
12:15 - 12:30
A three-dimensional ultrasound-based online system for automated ovarian follicle measurement
12:30 - 12:45
Mastering consistency: a similar training allows to standardize embryo transfer performance, but experience does not involve further improvements.
11:45 - 12:45
Session 91: Poster discussion session
11:45 - 12:45: Session 91: Poster discussion session:
13:00 - 14:00
Lunch break in the exhibit hall
13:00 - 14:00: Lunch break in the exhibit hall:
14:00 - 15:15
Session 92: Chilling Developments in Cryopreservation
14:00 - 15:15: Session 92: Chilling Developments in Cryopreservation:
Sofia Makieva, Switzerland
Chair invited, but not yet confirmed
14:00 - 14:15
Human oocyte survival, early embryo development, metabolic fingerprinting, and pregnancy outcomes following ultra-rapid or standard vitrification and thawing
14:15 - 14:30
Fast vitrification and warming protocols demonstrate similar efficiencies to a standard method and a substantial reduction in execution times.
14:30 - 14:45
The benefits of higher concentrations of synthetic serum substitutes in post-warming embryo culture and transfer media: a retrospective study of 864 frozen blastocyst transfer cycles
Giulia D'Alessandro, Italy
14:45 - 15:00
Prediction of pregnancy outcomes of single vitrified-warmed blastocyst transfer using combination of an automatic classification algorithm applied on cleavage stage embryos and blastocyst morphology
15:00 - 15:15
Embryo long-term storage does not affect ART outcome: analysis of 58,001 vitrified blastocysts
JOSE BELLVER PRADAS, Spain
14:00 - 15:15
Session 93: Smarter Strategies to Optimal Ovarian Stimulation - Time to Rethink (Part 2)
14:00 - 15:15: Session 93: Smarter Strategies to Optimal Ovarian Stimulation - Time to Rethink (Part 2):
Chair invited, but not yet confirmed
14:00 - 14:15
Exposure of antral follicles to progestins during stimulation does not cause molecular perturbations in gonadotropin-responsiveness and steroidogenic function of granulosa cells in progestin-primed IVF cycles
14:15 - 14:30
Dydrogesterone versus GnRH-antagonists to supress the LH surge in IVF/ICSI cycles
Ludmila Barbakadze, Georgia
14:30 - 14:45
Progesterone Primed Ovarian Stimulation (PPOS) for DuoStim combined with PGT-A in poor prognosis patients: a valuable strategy.
14:45 - 15:00
Feasibility and efficacy of a flexible and simplified ovarian stimulation protocol for oocyte donors, combining random-start corifollitropin alpha and progestin primed ovarian stimulation protocol (PPOS)
Emmanuelle Mathieu D'Argent, United Kingdom
15:00 - 15:15
What is the ideal dose of daily FSH after corifollitropin-alfa? A multicentre-randomized control trial.
14:00 - 15:15
Session 94: Investigating factors affecting sperm quality
14:00 - 15:15: Session 94: Investigating factors affecting sperm quality:
Chair invited, but not yet confirmed
14:00 - 14:15
Is there any association between thyroid-stimulating hormone (TSH) levels and semen parameters? A retrospective study in a European fertility clinic
AliReza Alizadeh Moghadam Masouleh, Iran
14:15 - 14:30
Mapping the entire functionally active seminal microbiota and its association with semen quality parameters
Eduardo Salas-Espejo, Spain
14:30 - 14:45
Sperm DNA methylome changes in testicular cancer patients following chemotherapy treatment
14:45 - 15:00
Decrease of human sperm hypercondensed chromatin volume after slow freezing revealed by three-dimensional (3D) nuclear morphometry
15:00 - 15:15
Is AI the future of sperm quality assessment? A comparative study of AI-enhanced and conventional semen analysis systems
Gemma López Granollers, Spain
14:00 - 15:15
Session 95: Cancer diagnosis, treatment and future fertility potential
14:00 - 15:15: Session 95: Cancer diagnosis, treatment and future fertility potential:
Isabelle Demeestere, Belgium
Chair invited, but not yet confirmed
14:00 - 14:15
Safety and fertility potential of residual ovarian cortex surrounding borderline tumors in women of reproductive age
Luciana Cacciottola, Belgium
14:15 - 14:30
PARP inhibitors have no toxic effect on follicle reserve, mitotic and steroidogenic function of granulosa cells in human ovary
14:30 - 14:45
Oncological treatments have limited effects on the fertility prognosis in testicular cancer: A systematic review and meta-analysis
14:45 - 15:00
Home semen freezing for fertility patients at the time of global travel restrictions due to COVID-19 pandemic
Sergey Moskovtsev, Canada
15:00 - 15:15
Increased risk of preterm deliveries in long term survivors of children, adolescent, and young adult exposure to chemotherapy or chemo-radiotherapy: A systematic review and meta-analysis
14:00 - 15:15
Session 96: Recurrent Pregnancy Loss: Perspectives from Epidemiology, Embryology and Clinical Practice
14:00 - 15:15: Session 96: Recurrent Pregnancy Loss: Perspectives from Epidemiology, Embryology and Clinical Practice:
Henriette Svarre Nielsen, Denmark
14:00 - 14:15
Investigating the embryonic contribution to recurrent pregnancy loss: a retrospective analysis of embryo quality, chromosomal status and morphokinetics in 11,169 embryos
Irene Miguel-Escalada, Spain
14:15 - 14:30
Familial endocrine disease increases the risk of pregnancy loss and recurrent pregnancy loss– a nationwide register-based study of 366,548 Danish women
14:30 - 14:45
Clinical application of PGT-A for recurrent pregnancy loss, what effects live birth after single euploid blastocyst transfer?
Fazilet Kubra Boynukalin, Turkey
14:45 - 15:00
Recurrent Miscarriage and Infertility : A Qualitative Study of Views and Experiences of Services in the Republic of Ireland
15:00 - 15:15
Decline of βhCG concentrations following pregnancy loss: exploring contributing factors
14:00 - 15:00
Session 97: Exchange session
14:00 - 15:00: Session 97: Exchange session:
14:00 - 15:15
Session 98: Embryology as the Foundation: From Time-Lapse to ART Outcomes
14:00 - 15:15: Session 98: Embryology as the Foundation: From Time-Lapse to ART Outcomes:
Amy Barrie, United Kingdom
Hanna Kostelijk, The Netherlands
14:00 - 14:15
A randomised trial of time-lapse imaging of embryos in in-vitro-fertilisation treatment
Priya Bhide, United Kingdom
14:15 - 14:30
A Foundation Model for Embryology Trained on Time-lapse Images
14:30 - 14:45
Sex-dependent discrepancies in automatic scoring: implications for the performance of embryo evaluation and selection methods
14:45 - 15:00
What is the number of IVF cycles needed to produce at least one euploid blastocyst in patients of all ages with varied AMH levels.
Yousef Alhelou, United Arab Emirates
15:00 - 15:15
Does applying an ‘elective freeze-all’ policy work in practice? A matched cohort study of over 9,000 embryo transfers
Jemma Garratt, United Kingdom
15:30 - 16:30
Closing reception
15:30 - 16:30: Closing reception:
10:00 - 11:00
EuMAR meeting
10:00 - 11:00: EuMAR meeting:
13:00 - 14:00
Young Talent Group meeting
13:00 - 14:00: Young Talent Group meeting:
13:00 - 14:00
ESHRE-Fertility Europe meeting
13:00 - 14:00: ESHRE-Fertility Europe meeting: